A

Aquestive Therapeutics

AQST

3.60000
USD
-0.23
(-6.01%)
Market Closed
Volume
15,779
EPS
0
Div Yield
0
P/E
-14
Market Cap
464,404,776
Related Instruments
A
ADMP
0
(0%)
0.000000 USD
A
AXSM
-1.255
(-1.44%)
86.075 USD
E
EGRX
-0.04000
(-0.83%)
4.78000 USD
JNJ
2.930
(1.86%)
160.770 USD
MRK
0.680
(0.60%)
113.800 USD
NVS
0.650
(0.58%)
112.100 USD
PFE
0.115
(0.38%)
30.650 USD
PG
4.847
(3.01%)
165.620 USD
T
TEVA
0.100
(0.57%)
17.530 USD
VRTX
9.75
(1.97%)
505.40 USD
News

Title: Aquestive Therapeutics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.